Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

SamanTree Medical, a leader in oncologic surgical imaging innovation, today announced promising results from the SHIELD study ...

Avril Mathie - who has clocked up a record of 8-1-1 since switching to the fight game after winning the Miss Swimsuit USA crown - believes the cosmetic procedure will pay off in the ring.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The 38-year-old actress - who started out as a child on 'The Cosby Show' and then found worldwide fame when she took on the title role of the Disney Channel sitcom 'That's So Raven' - revealed that ...

The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...

AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...

The findings from the study demonstrated a substantial decrease in reoperation rates when the Histolog scanner was utilised.

Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.

Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative ...

Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.